CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-03-15 | JACOBS CINDY EVP, CMO | Sale | −3,254 | $0.83 | $3K | 73,853 |
| 2016-03-15 | Bencich John CFO | Sale | −834 | $0.83 | $692 | 5,864 |
| 2016-03-15 | Cormack Scott Daniel President and CEO | Sale | −12,033 | $0.83 | $10K | 124,909 |
| 2016-03-14 | JACOBS CINDY EVP, CMO | Option exercise | +12,188 | 77,107 | ||
| 2016-03-14 | JACOBS CINDY EVP, CMO | Option exercise · Restricted Stock | −1,875 | 0 | ||
| 2016-03-14 | JACOBS CINDY EVP, CMO | Option exercise · Restricted Stock Unit (RSU) | −2,500 | 2,500 | ||
| 2016-03-14 | JACOBS CINDY EVP, CMO | Option exercise · Restricted Stock Unit (RSU) | −3,125 | 6,250 | ||
| 2016-03-14 | JACOBS CINDY EVP, CMO | Option exercise · Restricted Stock Unit (RSU) | −4,688 | 14,062 | ||
| 2016-03-14 | JACOBS CINDY EVP, CMO | Grant or award · Stock Option (right to buy) | +135,000 | 135,000 | ||
| 2016-03-14 | Bencich John CFO | Option exercise | +3,125 | 6,698 | ||
| 2016-03-14 | Bencich John CFO | Option exercise · Restricted Stock Unit (RSU) | −3,125 | 9,375 | ||
| 2016-03-14 | Bencich John CFO | Grant or award · Stock Option (right to buy) | +112,500 | 112,500 | ||
| 2016-03-14 | Cormack Scott Daniel President and CEO | Option exercise | +25,000 | 136,942 | ||
| 2016-03-14 | Cormack Scott Daniel President and CEO | Option exercise · Restricted Stock Unit (RSU) | −4,687 | 0 | ||
| 2016-03-14 | Cormack Scott Daniel President and CEO | Option exercise · Restricted Stock Unit (RSU) | −4,688 | 4,687 | ||
| 2016-03-14 | Cormack Scott Daniel President and CEO | Option exercise · Restricted Stock Unit (RSU) | −6,250 | 12,500 | ||
| 2016-03-14 | Cormack Scott Daniel President and CEO | Option exercise · Restricted Stock Unit (RSU) | −9,375 | 28,125 | ||
| 2016-03-14 | Cormack Scott Daniel President and CEO | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2016-03-14 | Cormack Scott Daniel President and CEO | Grant or award · Stock Option (right to buy) | +135,000 | 135,000 | ||
| 2015-10-28 | Clendeninn Neil James Director | Option exercise | +5,359 | $2.69 | $14K | 19,921 |
Page 23 of 36 · 715 trades